000			02114 a2200577 4500
005			20250516204018.0
264		0	_c20151217
008			201512s 0 0 eng d
022			_a1932-6203
024	7		_a10.1371/journal.pone.0089449 _2doi
040			_aNLM _beng _cNLM
100	1		_aGrépin, Renaud
245	0	0	_aThe relevance of testing the efficacy of anti-angiogenesis treatments on cells derived from primary tumors: a new method for the personalized treatment of renal cell carcinoma. _h[electronic resource]
260			_bPloS one _c2014
300			_ae89449 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAngiogenesis Inhibitors _xpharmacology
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aBasic Helix-Loop-Helix Leucine Zipper Transcription Factors _xgenetics
650	0	4	_aCarcinoma, Renal Cell _xdrug therapy
650	0	4	_aDisease Models, Animal
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aFemale
650	0	4	_aGene Expression
650	0	4	_aHumans
650	0	4	_aIndoles _xpharmacology
650	0	4	_aKidney Neoplasms _xdrug therapy
650	0	4	_aMice
650	0	4	_aMolecular Targeted Therapy
650	0	4	_aNeoplasm Metastasis
650	0	4	_aNeoplasm Staging
650	0	4	_aNeovascularization, Pathologic _xdrug therapy
650	0	4	_aNiacinamide _xanalogs & derivatives
650	0	4	_aPhenylurea Compounds _xpharmacology
650	0	4	_aPrecision Medicine
650	0	4	_aPyrroles _xpharmacology
650	0	4	_aReceptor Protein-Tyrosine Kinases _xantagonists & inhibitors
650	0	4	_aSorafenib
650	0	4	_aSunitinib
650	0	4	_aTumor Cells, Cultured
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aAmbrosetti, Damien
700	1		_aMarsaud, Alexandre
700	1		_aGastaud, Lauris
700	1		_aAmiel, Jean
700	1		_aPedeutour, Florence
700	1		_aPagès, Gilles
773	0		_tPloS one _gvol. 9 _gno. 3 _gp. e89449
856	4	0	_uhttps://doi.org/10.1371/journal.pone.0089449 _zAvailable from publisher's website
999			_c23683823 _d23683823